Q3 2026 13F filing
Updated 6 days ago41 disclosed positions worth $121M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | T TRAVERE THERAPEUTICS INC | $8.5M | 145.0K | 7.06% | — |
| 2 | C CYTOKINETICS INC | $8.4M | 128.0K | 6.97% | — |
| 3 | B BRIDGEBIO PHARMA INC | $6.6M | 100.0K | 5.44% | — |
| 4 | A ACADIA PHARMACEUTICALS INC | $6.4M | 320.0K | 5.33% | — |
| 5 | T TARSUS PHARMACEUTICALS INC | $5.5M | 70.0K | 4.55% | — |
| 6 | P PTC THERAPEUTICS INC | $5.2M | 80.0K | 4.28% | — |
| 7 | P PRAXIS PRECISION MEDICINES I | $5M | 17.0K | 4.09% | — |
| 8 | V VERA THERAPEUTICS INC | $4.8M | 150.0K | 4.00% | — |
| 9 | A ARCUTIS BIOTHERAPEUTICS INC | $4.8M | 180.0K | 3.93% | — |
| 10 | A ANNEXON INC | $4.7M | 1.12M | 3.92% | — |
| 11 | U UNITED THERAPEUTICS CORP DEL | $4.3M | 8.0K | 3.58% | — |
| 12 | N NEWAMSTERDAM PHARMA COMPANY | $3.9M | 160.0K | 3.22% | — |
| 13 | X XERIS BIOPHARMA HOLDINGS INC | $3.8M | 400.0K | 3.16% | — |
| 14 | C CELCUITY INC | $3.8M | 48.0K | 3.15% | — |
| 15 | D DBV TECHNOLOGIES S A | $3.2M | 270.0K | 2.62% | — |
| 16 | V VIRIDIAN THERAPEUTICS INC | $3.1M | 150.0K | 2.55% | — |
| 17 | Z ZENTALIS PHARMACEUTICALS INC | $3M | 1.08M | 2.47% | — |
| 18 | B BIOMARIN PHARMACEUTICAL INC | $2.9M | 48.0K | 2.38% | — |
| 19 | B BIOGEN INC | $2.7M | 12.0K | 2.24% | — |
| 20 | M MINERALYS THERAPEUTICS INC | $2.5M | 100.0K | 2.08% | — |
| 21 | L LIGAND PHARMACEUTICALS INC | $2.5M | 8.0K | 2.07% | — |
| 22 | R ULTRAGENYX PHARMACEUTICAL IN | $2.4M | 160.0K | 1.99% | — |
| 23 | P VAXCYTE INC | $2.3M | 40.0K | 1.88% | — |
| 24 | O ORIC PHARMACEUTICALS INC | $2.2M | 160.0K | 1.78% | — |
| 25 | A AXSOME THERAPEUTICS INC. | $1.8M | 10.0K | 1.52% | — |
| 26 | S SILENCE THERAPEUTICS PLC | $1.7M | 160.0K | 1.45% | — |
| 27 | B BEAM THERAPEUTICS INC | $1.7M | 70.0K | 1.41% | — |
| 28 | B BIOHAVEN LTD | $1.6M | 120.0K | 1.32% | — |
| 29 | R ULTRAGENYX PHARMACEUTICAL IN | $1.5M | 1.0K | 1.24% | — |
| 30 | C CONTINEUM THERAPEUTICS INC | $1.4M | 108.0K | 1.20% | — |
| 31 | G GENMAB A/S | $1.4M | 40.0K | 1.18% | — |
| 32 | N NEUROCRINE BIOSCIENCES INC | $1.1M | 8.0K | 0.94% | — |
| 33 | M MONOPAR THERAPEUTICS INC | $956K | 12.0K | 0.79% | — |
| 34 | M MOONLAKE IMMUNOTHERAPEUTICS | $936K | 80.0K | 0.77% | — |
| 35 | S ARS PHARMACEUTICALS INC | $862K | 200.0K | 0.71% | — |
| 36 | I IONIS PHARMACEUTICALS INC | $714K | 16.0K | 0.59% | — |
| 37 | O OLEMA PHARMACEUTICALS INC | $691K | 80.0K | 0.57% | — |
| 38 | L LEXICON PHARMACEUTICALS INC | $600K | 320.0K | 0.50% | — |
| 39 | W WAVE LIFE SCIENCES INC | $592K | 160.0K | 0.49% | — |
| 40 | S SAVARA INC | $413K | 80.0K | 0.34% | — |
| 41 | G GOSSAMER BIO INC | $284K | 24.0K | 0.23% | — |